CCLs can be broken down into:
- Columnar cell change (CCC): Corresponds to an increased relative risk of breast cancer. But the overall risk is low, therefore discovery at core needle biopsy requires no additional work-up.
- Columnar cell hyperplasia (CCH): Corresponds to an increased relative risk of breast cancer. But the overall risk is low, therefore discovery at core needle biopsy requires no additional work-up.
- Flat epithelial atypia (FEA): Commonly coexists with other more significant lesions, including ADH, DCIS, and tubular carcinoma. Therefore discovery at excisional biopsy should prompt in an excisional biopsy releveling of the block and a careful search for areas of ADH and DCIS.
Differential considerations for amorphous calcifications in the lobule or the terminal ducts incldues:
- DCIS
- ADH
- CCLs
- Ordinary epithelial hyperplasia
- Papillomatosis
- sclerosing adenosis
- DCIS
- ADH
- CCLs
- Typical ductal hyperplasia
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.